drugset / Trial / NCT01940692
Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA
RandomizedParallel-groupDouble-blindPrevention
Summary
Through a randomized controlled trial, we will compare the intravenous administration of tranexamic acid with the intra-articular application after a total hip arthroplasty through direct anterior approach. * RCT, prospective study * Academic-monocentric study * Clinical outcome measurements The postoperative blood loss will be the primary outcome. Secondary outcomes are 1. The rate of perioperative and postoperative blood transfusion 2. The number of blood units transfused 3. The length of hospital stay 4. Perioperative given intravenous isotonic fluid The Null-hypothesis is that there is no significant difference in postoperative blood loss between intra-articular and intravenous administration of TXA.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tranexamic Acid | Small molecule | 1.5 g | Intravenous |
| Comparator | Tranexamic Acid | Small molecule | 3 g | Intravenous |